Skip to main content
Signal8

LaCascia Michael

SEC insider (Form 3/4/5 filer). CIK 0001831755. Chief Legal Officer at Foghorn Therapeutics Inc. (FHTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in WATERTOWN, MA.

Companies LaCascia Michael has filed insider reports for

  • Foghorn Therapeutics Inc. (FHTX): Officer, Chief Legal Officer
LaCascia Michael profile photo

LaCascia Michael

CIK: 0001831755

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Foghorn Therapeutics Inc. logo
FHTX

Foghorn Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jan 30, 2026
    Award

    Stock option (right to buy)

    Direct
    295K shares at avg. $5.71-
  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jan 22, 2025
    Award

    Stock Option (right to buy)

    Direct
    126K shares at avg. $4.37-

1-2 of 2